TherapeuticsMD annual debt-to-equity ratio
2018
2019
2022
2023
2024
2025
TherapeuticsMD Debt-to-Equity Ratio Growth & History (TXMD)
TherapeuticsMD's debt-to-equity ratio was 0.23 for fiscal 2025.
View full TherapeuticsMD company overviewTherapeuticsMD annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.23 | −0.04 | −13.46% |
| 2024 | 2024-12-31 | 0.26 | −0.01 | −4.09% |
| 2023 | 2023-12-31 | 0.27 | 0.02 | +9.67% |
| 2022 | 2022-12-31 | 0.25 | — | — |
| 2019 | 2019-12-31 | 22.31 | 21.56 | +2865.12% |
| 2018 | 2018-12-31 | 0.75 | — | — |
TherapeuticsMD quarterly debt-to-equity ratio
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q4.19
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.20 | −0.04 | −15.31% |
| Q1 2026 | 2026-03-31 | 0.22 | −0.04 | −17.08% |
| Q4 2025 | 2025-12-31 | 0.23 | −0.04 | −13.46% |
| Q3 2025 | 2025-09-30 | 0.24 | — | — |
| Q2 2025 | 2025-06-30 | 0.24 | 0.18 | +321.36% |
| Q1 2025 | 2025-03-31 | 0.26 | — | — |
| Q4 2024 | 2024-12-31 | 0.26 | −0.01 | −4.09% |
| Q2 2024 | 2024-06-30 | 0.06 | −0.21 | −78.64% |
| Q4 2023 | 2023-12-31 | 0.27 | 0.02 | +9.67% |
| Q3 2023 | 2023-09-30 | 0.29 | — | — |
| Q2 2023 | 2023-06-30 | 0.27 | — | — |
| Q1 2023 | 2023-03-31 | 0.27 | — | — |
| Q4 2022 | 2022-12-31 | 0.25 | — | — |
| Q4 2019 | 2019-12-31 | 22.31 | 21.56 | +2865.12% |
| Q2 2019 | 2019-06-30 | 24.43 | 23.49 | +2490.55% |
| Q1 2019 | 2019-03-31 | 1.28 | — | — |
| Q4 2018 | 2018-12-31 | 0.75 | — | — |
| Q3 2018 | 2018-09-30 | 0.55 | — | — |
| Q2 2018 | 2018-06-30 | 0.94 | — | — |
TherapeuticsMD debt-to-equity ratio trends
Between the periods ended 2018-12-31 and 2025-12-31, TherapeuticsMD's debt-to-equity ratio decreased from 0.75 to 0.23, a change of −0.53. The latest reported quarter, Q2 2026, shows 0.20.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TherapeuticsMD source filings ↗